96.97
Healthequity Inc stock is traded at $96.97, with a volume of 35,769.
It is up +0.54% in the last 24 hours and up +0.51% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$96.50
Open:
$96.63
24h Volume:
35,769
Relative Volume:
0.04
Market Cap:
$8.36B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
88.97
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
+4.29%
1M Performance:
+0.51%
6M Performance:
+12.99%
1Y Performance:
+10.17%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
96.99 | 8.31B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
295.15 | 48.03B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
90.42 | 15.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
70.55 | 12.52B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.47 | 7.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Will HealthEquity Inc. bounce back from current supportJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Why HealthEquity Inc. stock is favored by pension fundsEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
How forex fluctuations impact HealthEquity Inc. (2HE) stockMarket Activity Recap & Accurate Technical Buy Alerts - newser.com
Will HealthEquity Inc. stock deliver consistent dividendsJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com
HealthEquity, Inc. $HQY Holdings Raised by Oppenheimer Asset Management Inc. - MarketBeat
Why HealthEquity Inc. stock is a must watch in 2025Treasury Yields & Fast Entry High Yield Stock Tips - newser.com
Pattern recognition hints at HealthEquity Inc. upsideProduct Launch & Technical Buy Zone Confirmation - newser.com
Will HealthEquity Inc. stock maintain dividend yieldPortfolio Update Report & Stepwise Trade Signal Guides - newser.com
Is HealthEquity Inc. (2HE) stock cheap vs fundamentalsTrade Volume Report & Technical Entry and Exit Tips - newser.com
Will HealthEquity Inc. stock go up soon2025 Price Targets & Risk Controlled Daily Plans - newser.com
Is HealthEquity Inc. (2HE) stock a buy before earnings resultsMarket Performance Report & Weekly Stock Performance Updates - newser.com
HealthEquity (NASDAQ:HQY) Given Hold (C+) Rating at Weiss Ratings - MarketBeat
Signal strength of HealthEquity Inc. stock in tech scanners2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
4,861 Shares in HealthEquity, Inc. $HQY Bought by Shaker Investments LLC OH - MarketBeat
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):